ELI LILLY & Co — Director's Dealing 2024

Jun 4, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-06-01

Reporting Person: Rau Diogo (EVP & CIDO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-01	Common Stock	M	6300	—	Acquired	14146	Direct
2024-06-01	Common Stock	F	3045	$820.34	Disposed	11101	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-01	Restricted Stock Unit	$	M	6300	Disposed		Common Stock (6300)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The restricted stock units vested in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024.